SGTX - Sigilon Therapeutics to effect 13-for-1 reverse stock split
2023-05-22 08:00:21 ET
- Sigilon Therapeutics ( NASDAQ: SGTX ) said on Monday that it will effect a 13-for-1 reverse stock split, effective the opening of trading on May 23.
- The company's shareholders had approved an amendment to the fifth amended and restated certificate of incorporation at the company's May 19 annual meeting of stockholders.
- The reverse stock split is expected to bring Sigilon in compliance with Nasdaq's minimum price requirement for continued listing.
- SGTX shares were trading -19.89% pre-market.
- Source: Press Release
For further details see:
Sigilon Therapeutics to effect 13-for-1 reverse stock split